Profil
Peter G.
Dworkin worked as the Director-Investor Relations at Matrix Pharmaceutical, Inc. from 1996 to 1999, and as the Head-Investor Relations at Protein Design Labs, Inc. from 1992 to 1996.
He was also the VP-Investor Relations & Corporate Communications at Applera Corp.
from 1999 to 2008.
Additionally, he held positions as Head-Corporate Communications & Media Relations at Regeneron Pharmaceuticals, Inc. in 2011, and as a Principal at TI Gotham, Inc., San Francisco Chronicle, and U.S.
News & World Report LP.
Dworkin earned an MBA degree from Haas School of Business.
Anciens postes connus de Peter G. Dworkin
| Sociétés | Poste | Fin |
|---|---|---|
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Public Communications Contact | 01/07/2008 |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Public Communications Contact | 01/01/1999 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Public Communications Contact | 01/01/1996 |
US News & World Report LP
US News & World Report LP Internet Software/ServicesTechnology Services Publishes news, analysis and rankings through online | Corporate Officer/Principal | - |
San Francisco Chronicle
San Francisco Chronicle Publishing: NewspapersConsumer Services Publishes daily newspaper | Corporate Officer/Principal | - |
Formation de Peter G. Dworkin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
TI Gotham, Inc.
TI Gotham, Inc. Publishing: Books/MagazinesConsumer Services Operates as magazine publisher and marketplace platform | Consumer Services |
San Francisco Chronicle
San Francisco Chronicle Publishing: NewspapersConsumer Services Publishes daily newspaper | Consumer Services |
US News & World Report LP
US News & World Report LP Internet Software/ServicesTechnology Services Publishes news, analysis and rankings through online | Technology Services |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















